Clincosm LogoSign in Get a demo

adenocarcinoma of lung

Showing 26 - 31 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma of Lung Trial in Belgium, Spain, United States (JNJ-64041757, Nivolumab)

Terminated
Has Results
  • Adenocarcinoma of Lung
  • Baltimore, Maryland
  • +9 more
Nov 23, 2019

Mesothelioma, Adenocarcinoma of Lung, Pancreatic Tumors Trial run by the NCI (Pentostatin, Cyclophosphamide, SS1(dsFv)PE38 - lot

Completed
Has Results
  • Mesothelioma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 5, 2019

The Tracking Molecular Evolution for NSCLC (T-MENC) Study

Unknown status
  • Lung Neoplasms
  • +3 more
    • Beijing, Beijing, China
    • +9 more
    Feb 10, 2019

    ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC

    Unknown status
    • Non-small Cell Lung Cancer Stage III
    • +3 more
    • ctDNA analysis
    • Hangzhou, Zhejiang, China
      Hangzhou First People's Hospital, Nanjing Medical University
    Oct 25, 2016

    Adenocarcinoma of Lung Trial in Hefei (recombinant human endostatin, pemetrexed plus cisplatin or carboplatin)

    Unknown status
    • Adenocarcinoma of Lung
    • recombinant human endostatin
    • pemetrexed plus cisplatin or carboplatin
    • Hefei, Anhui, China
      Anhui provincial hospital
    Jun 19, 2016

    Adenocarcinoma of Lung Trial (Cytokine-Induced Killer Cells, Apatinib)

    Active, not recruiting
    • Adenocarcinoma of Lung
    • (no location specified)
    Feb 4, 2016